Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: chirodoc who wrote (1109)	11/21/1998 1:20:00 AM
From: Anthony Wong	Read Replies (3) \| Respond to of 1722

Curtis, the rumors could stay around for a while. I don't mind which company buys out MTC, as long as the price is right. The new company would be a new entity, and needs separate evaluation on whether it would be a good long term investment, so I'll probably take some profit. A similar case in point, I've sold Humana (HUM) at $31 after it got a buyout offer. The merger didn't happen and HUM went down to $13. It's now at $19 something. I may buy the stock back again but there's a rumor swirling around that HUM is buying Oxford Health...so may be I'll wait around a bit. AHP and DD, if they want to do it, they could do it with a combination of cash and stock. Celebrex is going to be a money spinner, so there may not be too much dilution for the acquirer. Anthony